MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions

Standard

MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions. / Eken, Suzanne M; Jin, Hong; Chernogubova, Ekaterina; Li, Yuhuang; Simon, Nancy; Sun, Changyan; Korzunowicz, Greg; Busch, Albert; Bäcklund, Alexandra; Österholm, Cecilia; Razuvaev, Anton; Renné, Thomas; Eckstein, Hans-Henning; Pelisek, Jaroslav; Eriksson, Per; Gonzalez Diez, Maria; Matic Perisic, Ljubica P; Schellinger, Isabel N; Raaz, Uwe; Leeper, Nicholas J; Hansson, Göran K; Paulsson-Berne, Gabrielle; Hedin, Ulf; Maegdefessel, Lars.

in: CIRC RES, Jahrgang 120, Nr. 4, 17.02.2017, S. 633-644.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Eken, SM, Jin, H, Chernogubova, E, Li, Y, Simon, N, Sun, C, Korzunowicz, G, Busch, A, Bäcklund, A, Österholm, C, Razuvaev, A, Renné, T, Eckstein, H-H, Pelisek, J, Eriksson, P, Gonzalez Diez, M, Matic Perisic, LP, Schellinger, IN, Raaz, U, Leeper, NJ, Hansson, GK, Paulsson-Berne, G, Hedin, U & Maegdefessel, L 2017, 'MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions', CIRC RES, Jg. 120, Nr. 4, S. 633-644. https://doi.org/10.1161/CIRCRESAHA.116.309318

APA

Eken, S. M., Jin, H., Chernogubova, E., Li, Y., Simon, N., Sun, C., Korzunowicz, G., Busch, A., Bäcklund, A., Österholm, C., Razuvaev, A., Renné, T., Eckstein, H-H., Pelisek, J., Eriksson, P., Gonzalez Diez, M., Matic Perisic, L. P., Schellinger, I. N., Raaz, U., ... Maegdefessel, L. (2017). MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions. CIRC RES, 120(4), 633-644. https://doi.org/10.1161/CIRCRESAHA.116.309318

Vancouver

Eken SM, Jin H, Chernogubova E, Li Y, Simon N, Sun C et al. MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions. CIRC RES. 2017 Feb 17;120(4):633-644. https://doi.org/10.1161/CIRCRESAHA.116.309318

Bibtex

@article{1905b5de74884b41a3429453da512032,
title = "MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions",
abstract = "RATIONALE: In the search for markers and modulators of vascular disease, miRNAs have emerged as potent therapeutic targets.OBJECTIVE: To investigate miRNAs of clinical interest in patients with unstable carotid stenosis at risk of stroke.METHODS AND RESULTS: Utilizing patient material from the Biobank of Karolinska Endarterectomies (BiKE), we profiled miRNA expression in patients with stable vs unstable carotid plaque. A PCR-based miRNA array of plasma, sampled at the carotid lesion site, identified eight deregulated miRNAs (miR-15b, -29c, -30c/d, -150, -191, -210 and -500). miR-210 was the most significantly downregulated miRNA in local plasma material. Laser-capture microdissection as well as in situ hybridization revealed a distinct localization of miR-210 in fibrous caps. We confirmed that miR-210 directly targets the tumor suppressor gene adenomatous polyposis coli (APC), thereby affecting Wnt signaling and regulating smooth muscle cell survival, as well as differentiation in advanced atherosclerotic lesions. Substantial changes in arterial miR-210 were detectable in two rodent models of vascular remodeling and plaque rupture. Modulating miR-210 in vitro and in vivo improved fibrous cap stability with implications for vascular disease.CONCLUSIONS: An unstable carotid plaque at risk of stroke is characterized by low expression of miR-210. miR-210 contributes to stabilizing carotid plaques through inhibition of APC, ensuring smooth muscle cell survival. We present local delivery of miR-210 as a therapeutic approach for prevention of atherothrombotic vascular events.",
author = "Eken, {Suzanne M} and Hong Jin and Ekaterina Chernogubova and Yuhuang Li and Nancy Simon and Changyan Sun and Greg Korzunowicz and Albert Busch and Alexandra B{\"a}cklund and Cecilia {\"O}sterholm and Anton Razuvaev and Thomas Renn{\'e} and Hans-Henning Eckstein and Jaroslav Pelisek and Per Eriksson and {Gonzalez Diez}, Maria and {Matic Perisic}, {Ljubica P} and Schellinger, {Isabel N} and Uwe Raaz and Leeper, {Nicholas J} and Hansson, {G{\"o}ran K} and Gabrielle Paulsson-Berne and Ulf Hedin and Lars Maegdefessel",
year = "2017",
month = feb,
day = "17",
doi = "10.1161/CIRCRESAHA.116.309318",
language = "English",
volume = "120",
pages = "633--644",
journal = "CIRC RES",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "4",

}

RIS

TY - JOUR

T1 - MicroRNA-210 Enhances Fibrous Cap Stability in Advanced Atherosclerotic Lesions

AU - Eken, Suzanne M

AU - Jin, Hong

AU - Chernogubova, Ekaterina

AU - Li, Yuhuang

AU - Simon, Nancy

AU - Sun, Changyan

AU - Korzunowicz, Greg

AU - Busch, Albert

AU - Bäcklund, Alexandra

AU - Österholm, Cecilia

AU - Razuvaev, Anton

AU - Renné, Thomas

AU - Eckstein, Hans-Henning

AU - Pelisek, Jaroslav

AU - Eriksson, Per

AU - Gonzalez Diez, Maria

AU - Matic Perisic, Ljubica P

AU - Schellinger, Isabel N

AU - Raaz, Uwe

AU - Leeper, Nicholas J

AU - Hansson, Göran K

AU - Paulsson-Berne, Gabrielle

AU - Hedin, Ulf

AU - Maegdefessel, Lars

PY - 2017/2/17

Y1 - 2017/2/17

N2 - RATIONALE: In the search for markers and modulators of vascular disease, miRNAs have emerged as potent therapeutic targets.OBJECTIVE: To investigate miRNAs of clinical interest in patients with unstable carotid stenosis at risk of stroke.METHODS AND RESULTS: Utilizing patient material from the Biobank of Karolinska Endarterectomies (BiKE), we profiled miRNA expression in patients with stable vs unstable carotid plaque. A PCR-based miRNA array of plasma, sampled at the carotid lesion site, identified eight deregulated miRNAs (miR-15b, -29c, -30c/d, -150, -191, -210 and -500). miR-210 was the most significantly downregulated miRNA in local plasma material. Laser-capture microdissection as well as in situ hybridization revealed a distinct localization of miR-210 in fibrous caps. We confirmed that miR-210 directly targets the tumor suppressor gene adenomatous polyposis coli (APC), thereby affecting Wnt signaling and regulating smooth muscle cell survival, as well as differentiation in advanced atherosclerotic lesions. Substantial changes in arterial miR-210 were detectable in two rodent models of vascular remodeling and plaque rupture. Modulating miR-210 in vitro and in vivo improved fibrous cap stability with implications for vascular disease.CONCLUSIONS: An unstable carotid plaque at risk of stroke is characterized by low expression of miR-210. miR-210 contributes to stabilizing carotid plaques through inhibition of APC, ensuring smooth muscle cell survival. We present local delivery of miR-210 as a therapeutic approach for prevention of atherothrombotic vascular events.

AB - RATIONALE: In the search for markers and modulators of vascular disease, miRNAs have emerged as potent therapeutic targets.OBJECTIVE: To investigate miRNAs of clinical interest in patients with unstable carotid stenosis at risk of stroke.METHODS AND RESULTS: Utilizing patient material from the Biobank of Karolinska Endarterectomies (BiKE), we profiled miRNA expression in patients with stable vs unstable carotid plaque. A PCR-based miRNA array of plasma, sampled at the carotid lesion site, identified eight deregulated miRNAs (miR-15b, -29c, -30c/d, -150, -191, -210 and -500). miR-210 was the most significantly downregulated miRNA in local plasma material. Laser-capture microdissection as well as in situ hybridization revealed a distinct localization of miR-210 in fibrous caps. We confirmed that miR-210 directly targets the tumor suppressor gene adenomatous polyposis coli (APC), thereby affecting Wnt signaling and regulating smooth muscle cell survival, as well as differentiation in advanced atherosclerotic lesions. Substantial changes in arterial miR-210 were detectable in two rodent models of vascular remodeling and plaque rupture. Modulating miR-210 in vitro and in vivo improved fibrous cap stability with implications for vascular disease.CONCLUSIONS: An unstable carotid plaque at risk of stroke is characterized by low expression of miR-210. miR-210 contributes to stabilizing carotid plaques through inhibition of APC, ensuring smooth muscle cell survival. We present local delivery of miR-210 as a therapeutic approach for prevention of atherothrombotic vascular events.

U2 - 10.1161/CIRCRESAHA.116.309318

DO - 10.1161/CIRCRESAHA.116.309318

M3 - SCORING: Journal article

C2 - 27895035

VL - 120

SP - 633

EP - 644

JO - CIRC RES

JF - CIRC RES

SN - 0009-7330

IS - 4

ER -